Injectables Technology Platform Brochure

Injectables Technology Platform Brochure
Product Description

Your Expert Partner for Clinical & Commercial Sterile Injectable Drug Product Supply

  • Wide & balanced range of sterile injectable services, including capability for combining injectable drugs & devices (combination products)
  • Aseptic & Terminal Sterilization Fill & Finish Technologies for Pre-Filled Syringes (PFS), ampoules, liquid and lyophilized vials, supporting a wide range of filling volumes
  • Substantial Drug Product regulatory and filing experience globally (EMEA, FDA, PMDA)
  • Full-service CDMO offering, project management & integrated supply from APIs to final Drug Products
  • Packaging / labeling
  • Clinical trial drug kit management (logistics, track & trace, documentation)

Corden Pharma International GmbH

  • DE
  • 2015
    On CPHI since
  • 4
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO

Corden Pharma International GmbH

  • DE
  • 2015
    On CPHI since
  • 4
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO

More Products from Corden Pharma International GmbH (32)

  • CordenPharma Drug Product Support Services

    Product CordenPharma Drug Product Support Services

    SUPPORT SERVICES FOR OUR CONTRACTED CUSTOMERS • Analytical Development • Validation Support • Regulatory Support • Clinical Supply Services
  • CordenPharma Highly Potent APIs

    Product CordenPharma Highly Potent APIs

    With over 25 years of experience in the handling of Highly Potent Intermediates and Active Pharmaceutical Ingredients (APIs), CordenPharma utilises sophisticated technologies and the combined capabilities of multiple global cGMP facilities to produce Highly Potent pharmaceutical Drug Products and their API...
  • WeylChem InnoTec > Innovative Fine chemical, Pharmaceutical and Electronic Industry Partner

    Product WeylChem InnoTec > Innovative Fine chemical, Pharmaceutical and Electronic Industry Partner

    WeylChem InnoTec are your innovative partner to the fine chemical, pharmaceutical and electronic industry. We provide world-class analytical, modern developmental and tailor-made manufacturing services. With our competencies in Analytics, Contract Development & Custom Synthesis, WeylChem InnoTec is you...
  • CordenPharma BotaniChol® Plant-Based Cholesterol

    Product CordenPharma BotaniChol® Plant-Based Cholesterol

    Chemists at CordenPharma and the Otto-von-Guericke-University of Magdeburg, Germany developed a scalable synthesis of pharma-grade cholesterol based on botanical sources. This offers a large-scale production of highly needed cholesterol, which is used as part of the lipid cocktail ...
  • CordenPharma ONE PARTNER CDMO Video

    Product CordenPharma ONE PARTNER CDMO Video

    Your ONE PARTNER CDMO for Fully-Integrated Supply
    As your ONE PARTNER CDMO, CordenPharma provides contract manufacturing of APIs, Excipients, Drug Products & Packaging in an integrated solution spanning all product life cycle stages, from preclinical to commercial, supported by dedicated regulator...
  • Highly Potent & Oncology Technology Platform Brochure

    Product Highly Potent & Oncology Technology Platform Brochure

    One Source for Highly Potent & Oncological Products • Integrated Supply: APIs & Oral / Sterile Drug Products • State-of-the-art facilities able to handle API and Drug Product of the highest potency • Development, clinical trial and commercial manufacturing • Full-service offering in...
  • Peptides, Lipids & Carbohydrates Technology Platform Brochure

    Product Peptides, Lipids & Carbohydrates Technology Platform Brochure

    Your Expert Partner for Standard & Proprietary Lipids & Carbohydrates • A specialized Lipids offering including custom and standard lipids (Glycero-Phospholipids, Sphingolipids, Phosphocholine, Pegylated, and Cationic Lipids) • Lipids for support of mRNA vaccine production including Phospho...
  • Small Molecules Technology Platform Brochure

    Product Small Molecules Technology Platform Brochure

    Small Molecule Full-Service Partner of Choice from Advanced Intermediates to Drug Products • Integrated network of cGMP facilities across Europe and US • 1,200 m3 of volumetric capacity in 20 L - 28,000 L reactors with various materials of construction • Clinical (Phase I-III) and ongoing comme...
  • CordenPharma Oligonucleotides Platform

    Product CordenPharma Oligonucleotides Platform

    Your Expert Partner for Oligonucleotide APIs - Process Development & Small-scale: scale-up to 10 mmol per run (small-scale equipment can also support early-stage supply) - Scale-up & Small to Medium-scale: scale-up to 100 mmol per run (supported by OligoPilotTM equipment) - Large-Scale Oligonucleotide Pr...
  • CordenPharma's Early-Phase Peptide Centre of Excellence

    Product CordenPharma's Early-Phase Peptide Centre of Excellence

    In addition to the largest worldwide capacity of commercial SPPS peptide production up to batch sizes exceeding 400 kg (> 35 Amino Acids), and a yearly capacity of > 2 Metric Tons of Peptide, CordenPharma's multi-pronged approach to becoming the #1 peptide CDMO supplier extends to small-scale capabilities,...
  • Early-Phase Oral Solid Dose Drug Product Innovation Centre of Excellence

    Product Early-Phase Oral Solid Dose Drug Product Innovation Centre of Excellence

    CordenPharma’s Drug Product Innovation Centre of Excellence offers early phase formulation development and manufacturing services for Oral Solid Dose (OSD) drug products, including Bioavailability Enhancement technologies. In collaboration with our Solid State Centre of Excellence, we provide integrated AP...
  • Early-Phase Peptide Manufacturing Centre of Excellence

    Product Early-Phase Peptide Manufacturing Centre of Excellence

    In addition to enhanced large-scale peptide manufacturing with the world's largest SPPS facility available, CordenPharma's multi-pronged approach to becoming the #1 peptide CDMO supplier extends to small-scale capabilities, which started with expansions of non-GMP peptide capacity back in Q4 2020. Now Cord...

Corden Pharma International GmbH resources (2)